Invention Grant
- Patent Title: Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders
- Patent Title (中): 风险预测，诊断，预后和治疗肺功能障碍的方法和组成
-
Application No.: US13014589Application Date: 2011-01-26
-
Publication No.: US08673565B2Publication Date: 2014-03-18
- Inventor: David A. Schwartz , Max Seibold
- Applicant: David A. Schwartz , Max Seibold
- Applicant Address: US CO Denver
- Assignee: National Jewish Health
- Current Assignee: National Jewish Health
- Current Assignee Address: US CO Denver
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12P19/34 ; C07H21/02
Abstract:
The invention provides diagnostic and therapeutic targets for pulmonary disease, in particular, fibrotic lung disease. The inventors have found that a genetic variant MUC5B gene is associated with increased expression of the gene, increased risk of developing a pulmonary disease, and an improved prognosis and survival among those developing the pulmonary disease.
Public/Granted literature
- US20110217315A1 METHODS AND COMPOSITIONS FOR RISK PREDICTION, DIAGNOSIS, PROGNOSIS, AND TREATMENT OF PULMONARY DISORDERS Public/Granted day:2011-09-08
Information query
